Ozempic
Ozempic, a prescription medication produced by Novo Nordisk Inc. for Type-2 diabetes treatment, goes by the generic name semaglutide and falls under the category of GLP-1 agonists. These drugs imitate the action of a hormone naturally produced in the human body, known as glucagon-like peptide 1 (GLP-1). It is crucial to note that Ozempic is not FDA-approved for weight loss. However, it has gained significant popularity as an ‘off-label’ weight loss drug. Despite this, there has been a notable increase in reports of adverse gastrointestinal effects associated with Ozempic.
Learn If Your Case Is Eligible
Diving into a legal battle against a giant corporation may seem impossible, especially if you are dealing with illness. TortSource is here to make this journey as stress-free as possible for you, starting with a no-cost case review to answer all your questions and determine if you may qualify for a settlement.
🔒 All information is secure and will never be released
By providing your cell number you acknowledge and consent to receive and exchange communications via text messaging (SMS) and receive automated text messages and/or to receive and exchange communications via an automated telephone dialing system. Messaging and data rates may apply. Text “stop” to opt out at any time. No purchase necessary.
How It Works
Fill out the form or call us toll-free at 855-942-3317. We’ll be in touch within hours to hear your story, answer your questions, and determine if you may qualify for a settlement.
Allow us to gather key medical records and match you with a trusted legal expert who has won cases like yours.
We handle every aspect of building and fighting your case, so you can focus on living peacefully. You pay nothing if you aren’t awarded a settlement.
There are time deadlines to file a claim.
To discuss your claim immediately, click the “Call Us” button, or dial 855-942-3317
Plaintiffs in lawsuits involving Ozempic contend that the drug may induce a hazardous condition known as gastroparesis. A case report detailing the link between this medication and gastroparesis is accessible in the National Library of Medicine database. Gastroparesis is a chronic ailment characterized by significant weakening of the nerves and muscles in the stomach wall, making it challenging for the stomach to effectively move food to the small intestine. Consequences of gastroparesis include intestinal blockages or obstruction, often resulting in symptoms such as nausea and diarrhea. It’s important to note that gastroparesis is incurable and can only be managed through medical and surgical interventions. Consequently, individuals who have used Ozempic (semaglutide) and subsequently experienced severe gastrointestinal issues like gastroparesis and stomach paralysis may have grounds to pursue a personal injury lawsuit.
